Hegira Health Inc
-
Services:
- Smoking/vaping/tobacco cessation counseling
- Family counseling
- Individual counseling
- Group counseling
- Substance use disorder education
- Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
- Children/Adolescents
- Smoking permitted in designated area
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Female
- Male
- Clients who have experienced trauma
- Clients with co-occurring pain and substance use disorders
- Clients who have experienced intimate partner violence, domestic violence
- Clients with co-occurring mental and substance use disorders
- Criminal justice (other than DUI/DWI)/Forensic clients
- Clients who have experienced sexual abuse
- Comprehensive substance use assessment
- Screening for mental disorders
- Outreach to persons in the community
- Screening for tobacco use
- Comprehensive mental health assessment
- Screening for substance use
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Sliding fee scale (fee is based on income and other factors)
- Payment assistance (check with facility for details)
- Mental health services
- Case management service
- Social skills development
- Transportation assistance
- Vaping permitted in designated area
- State-financed health insurance plan other than Medicaid
- Federal military insurance (e.g., TRICARE)
- SAMHSA funding/block grants
- Cash or self-payment
- Medicare
- Medicaid
- Federal, or any government funding for substance use treatment programs
- Private health insurance
- Sign language services for the deaf and hard of hearing
- State mental health department
- State Substance use treatment agency
- The Joint Commission
- Private non-profit organization
- This facility administers/prescribes medication for alcohol use disorder
- Naltrexone (extended-release, injectable)
- Non-nicotine smoking/tobacco cessation
- Nicotine replacement
- Disulfiram
- Lofexidine
- Acamprosate (Campral®)
- Naltrexone (oral)
- Buprenorphine without naloxone
- Medication for mental disorders
- Clonidine
- Buprenorphine with naloxone
- Buprenorphine (extended-release, injectable)
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Buprenorphine maintenance
- Prescribes naltrexone
- Telemedicine/telehealth therapy
- Brief intervention
- Motivational interviewing
- Matrix Model
- Relapse prevention
- Trauma-related counseling
- Substance use disorder counseling
- Cognitive behavioral therapy
- Outcome follow-up after discharge
- Naloxone and overdose education
- Discharge Planning
- Aftercare/continuing care
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Intensive outpatient treatment
- Drug or alcohol urine screening
- No formal relationship with prescribing entity
- Assistance with obtaining social services
- Housing services
- Recovery coach
- Mentoring/peer support
- Employment counseling or training
Education and Counseling Services
Age Groups Accepted
Facility Smoking Policy
Opioid Medications used in Treatment
Gender Accepted
Special Programs/Groups Offered
Assessment/Pre-treatment
Type of Care
Payment Assistance Available
Ancillary Services
Facility Vaping Policy
Payment/Insurance/Funding Accepted
Language Services
License/Certification/Accreditation
Facility Operation (e.g., Private, Public)
Type of Alcohol Use Disorder Treatment
Pharmacotherapies
Type of Opioid Treatment
Treatment Approaches
Transitional Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Testing
External Source of Medications Used for Alcohol Use Disorder Treatment
Recovery Support Services